ISB News

New Publication in Cell Systems

April 25, 2017

A Cell-Surface Membrane Protein Signature for Glioblastoma

3 bullets:

  • Using integrated protein and gene expression data, ISB researchers developed a 33-gene signature for glioblastoma, an aggressive form of brain cancer.
  • Glioblastoma gene signatures are associated with TGF-b signaling and cancer invasion.
  • Researchers think that some of the glioblastoma gene signatures have the potential to be used as blood biomarkers for this aggressive cancer.

Read the full summary…

Related Articles

  • New Method to Detect, Analyze Rare T Cells Another Step Toward Personalized Cancer Vaccines

    Members of ISB’s Heath Lab and their collaborators have developed a way to sensitively detect and analyze neoantigen-specific T-cell populations from tumors and blood. This promising development may have implications for creating targeted, individual-specific cancer vaccines.

  • The Cancer Paradox

    ISB’s Dr. Sui Huang uses the theory of complex systems and applies it to cancer research. In this video Q&A, he discusses the cancer paradox and highlights the importance of understanding the mechanism of what cancer treatments can backfire in order to open a new avenue for therapy and treatments.

  • Dr. Wei Wei Awarded CARE Grant

    The Andy Hill Cancer Research Endowment (CARE) is a public-private partnership that supports cancer research in Washington state. CARE announced ISB Assistant Professor Dr. Wei Wei as a CARE Fund Distinguished Researcher and awarded him $500,000.

Show More Articles